Get the app
US › Healthcare

Cerenome, Inc. (CNSY)

US · Healthcare · Biotechnology

$2.03-0.49%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$411,000
Revenue YoY
-70.4%
Net profit
$-9.0M
Profit YoY
-274.8%
EPS
$-1.31
EPS estimate
$-0.96
Net margin
-2,191.2%

EPS came in at -1.31 against a street estimate of -0.96 — a miss of 36.5%.

Key statistics

Market cap
$17.6M
P/E
0.8
Forward P/E
1.0
P/B
3.32
Book value
$0.75
EPS (TTM)
$2.83
52-week high
$23.50
52-week low
$2.31
50-day MA
$3.53
200-day MA
$6.91
Beta
1.39

Analyst view

with an average price target of $36.00.

Shareholding

Insiders
1.66%
Institutions
15.30%

Largest institutional holders

FundStake
Geode Capital Management, LLC1.17%
BlackRock Inc1.03%
State Street Corp0.27%
Northern Trust Corp0.17%
XTX Topco Ltd0.07%
Citigroup Inc0.05%
UBS Group AG0.05%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.0.01%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Cerenome, Inc. — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.